维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="GHAYAD SE"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Inhibitors of the P13K/Akt/mTOR pathway: New hope for breast cancer patients显示文摘	Ghayad SE Cohen PA	2010	Recent Pat Anticancer Drug Diseov2010，5，1：	1
2	mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels显示文摘	Ghayad SE Bieche I Vendrell JA	2008	Cancer Sci2008，99，10：	1
3	Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3 K/Akt signaling pathways显示文摘	Ghayad SE Vendrell JA Larbi SB	2010	Int J Cancer2010，126，2：	1
4	mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels显示文摘	Ghayad SE Bieche I Vendrell JA	2008	Cancer Sci2008，99，10：	1
5	Inhibitors of the PI3K/Akt/m TOR pathway:new hope for breast cancer patients显示文摘	Ghayad SE Cohen PA	2010	Recenl Pat Anticancer Drug Discov2010，5，1：	1
6	Endocrine resistanceassociated with activated ErbB system in breast cancer cells is re-versed by inhibiting MAPK or PI3K/Akt signaling pathways显示文摘	Ghayad SE Vendrell JA Larbi SB	2010	Int J Cancer2010，126，：	1
7	Inhibitors of the PI3K/Akt/mTOR pathway:new hope for breast cancer patients显示文摘	Ghayad SE Cohen PA	2010	Recent Pat Anticancer Drug Discov2010，5，：	1
8	Inhibitors of the PI3K/Akt/mTOR pathway:new hope for breast cancer patients显示文摘	Ghayad SE Cohen PA	2010	Recent Pat Anticancer Drug Discov2010，5，1：	1
9	Endocrine resistance associated with activated ErbB system in breast cancer ceils is re-versed by inhibiting MAPK or P13 K/Akt signaling pathways 显示文摘	Ghayad SE VendreU JA Ben Larbi S	2010	lnt J Cancer2010，126，2：	1
10	Inhibitors of the PI3K/Akt/raTOR pathway: new hope for breast cancer patients 显示文摘	Ghayad SE Cohen PA	2010	Recent Pat Anticancer Drug Discovery2010，5，1：	1
11	Inhibitors of the PI3K/Akt/mTOR pathway:new hope for breast cancer patients 显示文摘	GHAYAD SE COHEN PA	2010	Recent Pat Antieaneer Drug Discov2010，5，1：	1
12	Inhibitors of the PI3K/Akt/mTOR pathway:new hope for breast cancer patients显示文摘	Ghayad SE Cohen PA	2010	Recent Pat Anticancer Drug Discov2010，5，1：	1
13	Endocrine resist- ance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or P13K/Akt signaling pathways 显示文摘	GHAYAD SE VENDRELL JA LARBI SB	2010	Int J Cancer2010，126，2：	1
14	Inhibitors of the PI3K1AktimTOR pathway: new hope for breast cancer patients显示文摘	Ghayad SE Cohen PA	2010	Recent Pat Anticancer Drug Discov2010，5，1：	1
15	Inhibitors of the PI3K/Akt/mTOR pathway: new hope for breast cancer patients显示文摘	Ghayad SE Cohen PA	2010	Recent Pat Anticancer Drug Discov2010，5，1：	1
16	Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways 显示文摘	Ghayad SE Vendrell JA Ben Larbi S	2010	Int J Cancer2010，126，2：	1
17	Identification of TACC1,NOV,and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer显示文摘	Ghayad SE Vendrell JA Bieche IS		0，，：	1
18	Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways显示文摘	Ghayad SE Vendrell JA Larbi SB	2010	Int J Cancer2010，126，2：	1
19	Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways显示文摘	Ghayad SE Vendrell JA Larbi SB		0，，：	1
20	Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways显示文摘	Ghayad SE Vendrell JA Larbi SB		0，，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示